STUART DORMAN - 11 Dec 2024 Form 3 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Chief Commercial Officer
Signature
/s/ Andres Ruiz Briseno, as Attorney-in-Fact for Stuart Dorman
Issuer symbol
IDYA
Transactions as of
11 Dec 2024
Net transactions value
$0
Form type
3
Filing time
20 Dec 2024, 16:53:22 UTC
Next filing
28 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IDYA Stock Option (Right to Buy) 11 Dec 2024 Common Stock 170,000 $27.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from December 2, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Exhibit 24.1 - Power of Attorney